BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22261944)

  • 21. Medication errors and adverse drug events in pediatric inpatients.
    Kaushal R; Bates DW; Landrigan C; McKenna KJ; Clapp MD; Federico F; Goldmann DA
    JAMA; 2001 Apr; 285(16):2114-20. PubMed ID: 11311101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients.
    Boeker EB; Ram K; Klopotowska JE; de Boer M; Creus MT; de Andrés AL; Sakuma M; Morimoto T; Boermeester MA; Dijkgraaf MG
    Br J Clin Pharmacol; 2015 Apr; 79(4):548-57. PubMed ID: 25199645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
    Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
    BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug events in adult patients leading to emergency department visits.
    Sikdar KC; Alaghehbandan R; MacDonald D; Barrett B; Collins KD; Donnan J; Gadag V
    Ann Pharmacother; 2010 Apr; 44(4):641-9. PubMed ID: 20233911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
    Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
    BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Return on investment for vendor computerized physician order entry in four community hospitals: the importance of decision support.
    Zimlichman E; Keohane C; Franz C; Everett WL; Seger DL; Yoon C; Leung AA; Cadet B; Coffey M; Kaufman NE; Bates DW
    Jt Comm J Qual Patient Saf; 2013 Jul; 39(7):312-8. PubMed ID: 23888641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients.
    Díaz Hernández SH; Cruz-Gonzalez I
    Consult Pharm; 2018 Aug; 33(8):454-466. PubMed ID: 30068439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated surveillance for adverse drug events at a community hospital and an academic medical center.
    Kilbridge PM; Campbell UC; Cozart HB; Mojarrad MG
    J Am Med Inform Assoc; 2006; 13(4):372-7. PubMed ID: 16622159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying drug safety issues: from research to practice.
    Gandhi TK; Seger DL; Bates DW
    Int J Qual Health Care; 2000 Feb; 12(1):69-76. PubMed ID: 10733086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.
    Hakkarainen KM; Gyllensten H; Jönsson AK; Andersson Sundell K; Petzold M; Hägg S
    Br J Clin Pharmacol; 2014 Jul; 78(1):170-83. PubMed ID: 24372506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: a study protocol.
    Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P
    BMJ Open; 2016 Oct; 6(10):e011811. PubMed ID: 27797997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for assessing the preventability of adverse drug events: a systematic review.
    Hakkarainen KM; Andersson Sundell K; Petzold M; Hägg S
    Drug Saf; 2012 Feb; 35(2):105-26. PubMed ID: 22201475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
    Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
    BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential risks and prevention, Part 4: Reports of significant adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Aug; 58(15):1406-12. PubMed ID: 11494785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.
    Koutkias VG; McNair P; Kilintzis V; Skovhus Andersen K; Niès J; Sarfati JC; Ammenwerth E; Chazard E; Jensen S; Beuscart R; Maglaveras N
    Methods Inf Med; 2014; 53(6):482-92. PubMed ID: 25377477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital.
    Raschke RA; Gollihare B; Wunderlich TA; Guidry JR; Leibowitz AI; Peirce JC; Lemelson L; Heisler MA; Susong C
    JAMA; 1998 Oct; 280(15):1317-20. PubMed ID: 9794309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of medication-related clinical decision support alert overrides in the intensive care unit.
    Wong A; Amato MG; Seger DL; Slight SP; Beeler PE; Dykes PC; Fiskio JM; Silvers ER; Orav EJ; Eguale T; Bates DW
    J Crit Care; 2017 Jun; 39():156-161. PubMed ID: 28259059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.